Znn3bq.jpeg
²é¿´: 1095  |  »Ø¸´: 15
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û11´Î£¬×÷Õßluai071Ôö¼Ó½ð±Ò 8.5 ¸ö
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

luai071

ľ³æ (ÖøÃûдÊÖ)


[×ÊÔ´] ÍÆ¼öWileyµç×ÓÊéÒ»±¾

G Protein-Coupled Receptors as Drug Targets: Analysis of Activation and Constitutive Activity
Publisher:  Wiley-VCH
Number Of Pages:  304
Publication Date:  2006-01-09
Sales Rank:  488335
ISBN / ASIN:  3527308199
EAN:  9783527308194
Binding:  Hardcover
Manufacturer:  Wiley-VCH
Studio:  Wiley-VCH


Book Description:

With its particular emphasis on the constitutive activity of G-protein-coupled receptors (GPCRs)s, this book comprehensively discusses an important biological process that has not yet been covered in such depth in any other existing books on GPCRs. The international team of highly distinguished authors addresses in detail current models and concepts, to introduce medicinal chemists, physiologists, pharmacologists, and medical researchers into the advances in the understanding of GPCR activation and constitutive activity. In addition, the book freeduan.com provides an overview on methods of investigating constitutive GPCR activity. The text is well illustrated by selected experimental data and schemes._The chaptes are all cross-referenced with each other and cover general mechnisms, methodological approaches and cover selected important GPCR sysstems, the consequences for drug action, including, side effects, and rational drug design for GPCR targets. A highly recommended reference for researchers in academia and industry.

authors addresses in detail current models and concepts, so as to introduce pharmaceutical chemists, physiologists and medical researchers to the advances in the understanding of GPCR activation and constitutive activity, and provides an overview of the methods of investigating GPCR activity. The text is backed by abundant case studies and methodological advice for analyzing GPCRs, covering selected pharmacologically relevant GPCR systems, the consequences for drug action, including unwanted side effects, and rational drug design for GPCR targets.
A highly practical reference for researchers in academia and industry.
http://www.daydownload.com/hosting.php?ref=cl3s8ZTaBwtS
http://www.daydownload.com/hosting.php?ref=61nFwsl3I1vU

[ Last edited by luai071 on 2007-6-9 at 15:18 ]
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

az_kevin

½ð³æ (СÓÐÃûÆø)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

лл¡£
8Â¥2007-06-21 14:54:07
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 16 ¸ö»Ø´ð

wangye

½ûÑÔ (ÕýʽдÊÖ)

±¾ÌûÄÚÈݱ»ÆÁ±Î

2Â¥2007-06-09 18:12:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

cmuchchem

½ð³æ (ÕýʽдÊÖ)


¡ï Ò»ÐǼ¶,Ò»°ã

2¸öÎļþ¶¼ÒªÏÂÔØ¡£È»ºó¸Ä³ÉͬÃû£¬ÀýÈç°Ñ´óÎļþÃüÃûΪwww1.rar£¬Ð¡ÎļþΪwww2.rar£¬ÔÙ½âѹ¡£
3Â¥2007-06-09 18:47:40
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wangye

½ûÑÔ (ÕýʽдÊÖ)

±¾ÌûÄÚÈݱ»ÆÁ±Î

4Â¥2007-06-09 19:06:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 0854Çóµ÷¼Á +3 ÃÅ·ÃþÃþ 2026-04-15 3/150 2026-04-15 16:34 by Litexin
[¿¼ÑÐ] 297£¬¹¤¿Æµ÷¼Á? +7 ºÓÄÏũҵ´óѧ-ÄÜ 2026-04-14 7/350 2026-04-15 13:26 by Î÷±±Íû¡ª·çɳ
[¿¼ÑÐ] 273Çóµ÷¼Á +5 °×¾Ó²»Ò×. 2026-04-09 7/350 2026-04-15 13:16 by Î÷±±Íû¡ª·çɳ
[¿¼ÑÐ] 296Çóµ÷¼Á +10 Íô£¡£¿£¡ 2026-04-09 11/550 2026-04-15 09:17 by fenglj492
[¿¼ÑÐ] 291 Çóµ÷¼Á +38 »¯¹¤2026½ì±ÏÒµÉ 2026-04-09 39/1950 2026-04-15 08:03 by ²»ÎÒÀ­ÂÌ¿¨
[¿¼ÑÐ] 08¹¤Ñ§ 309·ÖÇóµ÷¼Á +12 Yin DY 2026-04-08 12/600 2026-04-14 17:49 by lhj2009
[¿¼ÑÐ] 367Çóµ÷¼Á +11 hffQAQ 2026-04-09 11/550 2026-04-14 17:48 by lhj2009
[¿¼ÑÐ] 271Çóµ÷¼Á +35 2261744733 2026-04-11 41/2050 2026-04-14 15:36 by zs92450
[¿¼ÑÐ] Ò»Ö¾Ô¸ÏôóÉúÎïѧ332Çóµ÷¼Á +11 ³Ø³Ø³Ø³Ø³Ø³Ø 2026-04-08 11/550 2026-04-13 14:10 by ¿ÆÑÐÂÛ
[¿¼ÑÐ] Ò»Ö¾Ô¸085802 323·ÖÇóµ÷¼Á +13 drizzle_9 2026-04-12 14/700 2026-04-13 10:26 by Faiz5552
[¿¼ÑÐ] 344 ²ÄÁÏרҵ Çóµ÷¼Á211 ÎÞµØÓòÒªÇó +8 hualkop 2026-04-11 8/400 2026-04-12 22:24 by fqwang
[˶²©¼ÒÔ°] ÐÂÒ»´úµç×ÓÐÅÏ¢294Çóµ÷¼Á ²»ÌôѧУ +7 Ytyt11 2026-04-09 8/400 2026-04-12 16:57 by ajpv·çÀ×
[¿¼ÑÐ] 307Çóµ÷¼Á +10 tzq94092 2026-04-10 10/500 2026-04-12 08:18 by wise999
[¿¼ÑÐ] ²ÄÁϹ¤³ÌÈÕÓÉúÇóµ÷¼Á +7 0856?µ÷¼Á 2026-04-10 7/350 2026-04-11 21:33 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ¹¤¿Æ273µ÷¼Á +6 X1999 2026-04-09 7/350 2026-04-11 10:23 by zhq0425
[¿¼ÑÐ] 085402ͨÐŹ¤³Ìµ÷¼Á£¬ÓÐ4Ïîѧ¿Æ¾ºÈü¹ú½±£¨µçÈü¹ú¶þ£©£¬Ë¶Ê¿Ñо¿Éúµ÷¼Á×Ô¼öÐÅ¡£ +5 mÓÀo²»vÑÔoÆúm 2026-04-09 5/250 2026-04-11 09:33 by zhq0425
[¿¼ÑÐ] 263ÄÜÔ´¶¯Á¦×¨Ë¶Çóµ÷¼Á +3 ¼Ó´óºÅ·¹ºÐ´ü 2026-04-10 3/150 2026-04-10 22:23 by 286640313
[¿¼ÑÐ] 301Çóµ÷¼Á +5 149. 2026-04-10 5/250 2026-04-10 15:45 by ²ñС°×
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖпÆÔº105500רҵ×Ü·Ö315Çóµ÷¼Á +6 lallalh 2026-04-09 7/350 2026-04-09 17:51 by lallalh
[¿¼ÑÐ] ÕÐÊÕÓлú»¯Ñ§¡¢»¯¹¤£¬Ò©Ñ§£¬Ê³Æ·µÆ×¨ÒµÑ§Éú +3 yrfhjgdj 2026-04-08 3/150 2026-04-09 10:15 by QYQX_123
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û